Paul A Hamlin

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 19

Top Topics

Hodgkin Lymphoma

Diffuse Large B Cell Lymphoma

Top Venues

American journal of hematology

Cancer research communications

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Ashwath Gurumurthi, Kurt S Bantilan, Paul A Hamlin, Anita Kumar, Matthew J Matasar, Menglei Zhu, Ashlee Joseph, Ali Castro, Erin Biggar, Gilles Andre Salles, Andrew D Zelenetz, Gottfried von Keudell
A phase 1 trial of abexinostat with ibrutinib in relapsed/refractory mantle cell lymphoma and non-germinal center diffuse large B cell lymphoma. Leukemia & lymphoma (2024)
Kurt S Bantilan, Alexandra N Smith, Matthew John Maurer, Julie Teruya-Feldstein, Matthew J Matasar, Alison J Moskowitz, David J Straus, Ariela Noy, M Lia Palomba, Steven M Horwitz, Paul A Hamlin, Carol S Portlock, James R Cerhan, Thomas M Habermann, Gilles Andre Salles, Grzegorz S Nowakowski, Craig H Moskowitz, Andrew D Zelenetz
Matched control analysis suggests R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared to R-CHOP. Blood advances (2024)
Kurt S Bantilan, Alexandra N Smith, Matthew John Maurer, Julie Teruya-Feldstein, Matthew J Matasar, Alison J Moskowitz, David J Straus, Ariela Noy, Maria Lia Palomba, Steven M Horwitz, Paul A Hamlin, Carol S Portlock, James R Cerhan, Thomas M Habermann, Gilles Andre Salles, Grzegorz S Nowakowski, Craig H Moskowitz, Andrew D Zelenetz
Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP. Blood advances 8 (9) (2024)
Kurt S Bantilan, Alexandra N Smith, Matthew John Maurer, Julie Teruya-Feldstein, Matthew J Matasar, Alison J Moskowitz, David J Straus, Ariela Noy, Maria Lia Palomba, Steven M Horwitz, Paul A Hamlin, Carol S Portlock, James R Cerhan, Thomas M Habermann, Gilles Andre Salles, Grzegorz S Nowakowski, Craig H Moskowitz, Andrew D Zelenetz
Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP. Blood advances 8 (9) (2024)
Kurt S Bantilan, Alexandra N Smith, Matthew John Maurer, Julie Teruya-Feldstein, Matthew J Matasar, Alison J Moskowitz, David J Straus, Ariela Noy, Maria Lia Palomba, Steven M Horwitz, Paul A Hamlin, Carol S Portlock, James R Cerhan, Thomas M Habermann, Gilles Andre Salles, Grzegorz S Nowakowski, Craig H Moskowitz, Andrew D Zelenetz
Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP. Blood advances 8 (9) (2024)
Kurt S Bantilan, Alexandra N Smith, Matthew John Maurer, Julie Teruya-Feldstein, Matthew J Matasar, Alison J Moskowitz, David J Straus, Ariela Noy, Maria Lia Palomba, Steven M Horwitz, Paul A Hamlin, Carol S Portlock, James R Cerhan, Thomas M Habermann, Gilles Andre Salles, Grzegorz S Nowakowski, Craig H Moskowitz, Andrew D Zelenetz
Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP. Blood advances 8 (9) (2024)
Kurt S Bantilan, Alexandra N Smith, Matthew John Maurer, Julie Teruya-Feldstein, Matthew J Matasar, Alison J Moskowitz, David J Straus, Ariela Noy, M Lia Palomba, Steven M Horwitz, Paul A Hamlin, Carol S Portlock, James R Cerhan, Thomas M Habermann, Gilles Andre Salles, Grzegorz S Nowakowski, Craig H Moskowitz, Andrew D Zelenetz
Matched control analysis suggests R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared to R-CHOP. Blood advances (2024)
Kurt S Bantilan, Alexandra N Smith, Matthew John Maurer, Julie Teruya-Feldstein, Matthew J Matasar, Alison J Moskowitz, David J Straus, Ariela Noy, M Lia Palomba, Steven M Horwitz, Paul A Hamlin, Carol S Portlock, James R Cerhan, Thomas M Habermann, Gilles Andre Salles, Grzegorz S Nowakowski, Craig H Moskowitz, Andrew D Zelenetz
Matched control analysis suggests R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared to R-CHOP. Blood advances (2024)
Richard J Lin, Soo Jung Kim, Samantha Brown, Theresa A Elko, Josel D Ruiz, Danielle M Hanley, M Lia Palomba, Miguel-Ángel Perales, Gunjan L Shah, Parastoo B Dahi, Michael Scordo, Craig S Sauter, Connie Lee Batlevi, Ana Alarcon Tomas, Roni Shouval, Nicole Lee, Emma A Pavkovic, Danielle E Engstler, Jae H Park, Gilles Andre Salles, Sean M Devlin, Beatriz Korc-Grodzicki, Paul A Hamlin, Sergio A Giralt
Prospective Geriatric Assessment and Geriatric Consultation in CAR T-cell Therapy for Older Lymphoma Patients. Blood advances (2023)
Robert N Stuver, Esther Drill, David Qualls, Michelle Okwali, Connie Lee Batlevi, Philip C Caron, Ahmet Dogan, Zachary D Epstein-Peterson, Lorenzo Falchi, Paul A Hamlin, Steven M Horwitz, Brandon S Imber, Andrew M Intlekofer, William T Johnson, Niloufer Khan, Anita Kumar, Oscar B Lahoud, Jennifer Kimberly Lue, Matthew J Matasar, Alison J Moskowitz, Ariela Noy, Colette N Owens, M Lia Palomba, Heiko Schöder, Santosha A Vardhana, Joachim Yahalom, Andrew D Zelenetz, Gilles Andre Salles, David J Straus
Retrospective Characterization of Nodal Marginal Zone Lymphoma. Blood advances (2023)
William T Johnson, Nivetha Ganesan, Zachary D Epstein-Peterson, Alison J Moskowitz, Robert N Stuver, Catherine R Maccaro, Natasha Galasso, Tiffany Chang, Niloufer Khan, Umut Aypar, Natasha E Lewis, Andrew D Zelenetz, M Lia Palomba, Matthew J Matasar, Ariela Noy, Audrey M Hamilton, Paul A Hamlin, Philip C Caron, David J Straus, Andrew M Intlekofer, Connie Lee Batlevi, Anita Kumar, Colette N Owens, Craig S Sauter, Lorenzo Falchi, Jennifer K Lue, Santosha A Vardhana, Gilles Andre Salles, Ahmet Dogan, Nikolaus D Schultz, Maria E Arcila, Steven M Horwitz
TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy. Blood advances (2023)
Paul A Hamlin, Vasile Musteata, Steven I Park, Christine Burnett, Kristina Dabovic, Thomas Strack, Eric T Williams, Banmeet S Anand, Jack P Higgins, Daniel O Persky
Safety and Efficacy of Engineered Toxin Body MT-3724 in Relapsed or Refractory B-cell Non-Hodgkin's Lymphomas and Diffuse Large B-cell Lymphoma. Cancer research communications 2 (5) (2022)
Paul A Hamlin, Vasile Musteata, Steven I Park, Christine Burnett, Kristina Dabovic, Thomas Strack, Eric T Williams, Banmeet S Anand, Jack P Higgins, Daniel O Persky
Safety and Efficacy of Engineered Toxin Body MT-3724 in Relapsed or Refractory B-cell Non-Hodgkin's Lymphomas and Diffuse Large B-cell Lymphoma. Cancer research communications 2 (5) (2022)
Parastoo Bahrami Dahi, Jasme Lee, Sean M Devlin, Josel Ruiz, Molly Maloy, Carlos Rondon-Clavo, Erica Petrlik, Roni Tamari, Gunjan Shah, Michael Scordo, Matthew J Matasar, Paul A Hamlin, Esperanza Papadopoulos, Ann A Jakubowski, Miguel-Ángel Perales, Craig H Moskowitz, Craig S Sauter, Sergio A Giralt
Toxicities of high-dose chemotherapy and autologous hematopoietic cell transplantation in older patients with lymphoma. Blood advances 5 (12) (2021)
Brandon S Imber, Karen W Chau, Jasme Lee, Jisun Lee, Dana L Casey, Joanna C Yang, N Ari Wijentunga, Annemarie Shepherd, Carla Hajj, Shunan Qi, Monica R Chelius, Paul A Hamlin, M Lia Palomba, Erel Joffe, Zhigang Zhang, Andrew D Zelenetz, Gilles Andre Salles, Joachim Yahalom
Excellent response to very-low-dose radiation (4 Gy) for indolent B-cell lymphomas: is 4 Gy suitable for curable patients? Blood advances 5 (20) (2021)
Caitlin M Stewart, Laure Michaud, Karissa A Whiting, Reiko Nakajima, Chelsea Nichols, Stephanie De Frank, Paul A Hamlin, Matthew J Matasar, John F Gerecitano, Pamela Drullinsky, Audrey Hamilton, David Straus, Steven M Horwitz, Anita Kumar, Craig H Moskowitz, Alison Moskowitz, Andrew D Zelenetz, Jurgen Rademaker, Gilles Andre Salles, Venkatraman Seshan, Heiko Schöder, Anas Younes, Dana W Y Tsui, Connie Lee Batlevi
Phase I/Ib Study of the Efficacy and Safety of Buparlisib and Ibrutinib Therapy in MCL, FL, and DLBCL with Serial Cell-Free DNA Monitoring. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Neha Mehta-Shah, Matthew A Lunning, Alison J Moskowitz, Adam M Boruchov, Jia Ruan, Peggy Lynch, Paul A Hamlin, John Leonard, Matthew J Matasar, Patricia L Myskowski, Evan Marzouk, Sumithra Nair, Tamir Sholklapper, Veena Minnal, Maria L Palomba, James Vredenburgh, Anita Kumar, Ariela Noy, David J Straus, Andrew D Zelenetz, Heiko Schoder, Jurgen Rademaker, Wendy Schaffer, Natasha Galasso, Nivetha Ganesan, Steven M Horwitz
Romidepsin and lenalidomide-based regimens have efficacy in relapsed/refractory lymphoma: Combined analysis of two phase I studies with expansion cohorts. American journal of hematology 96 (10) (2021)
Paul A Hamlin, Ian W Flinn, Nina Wagner-Johnston, Jan A Burger, Greg P Coffey, Pamela B Conley, Glenn Michelson, Janet M Leeds, Kenneth Der, Yvonne Kim, Alice Sabalvaro-Torres, Matt Birrell, Anjali Pandey, John T Curnutte, Manish R Patel
Efficacy and safety of the dual SYK/JAK inhibitor cerdulatinib in patients with relapsed or refractory B-cell malignancies: Results of a phase I study. American journal of hematology 94 (4) (2019)
Sven Borchmann, Erel Joffe, Craig H Moskowitz, Andrew D Zelenetz, Ariela Noy, Carol S Portlock, John F Gerecitano, Connie Lee Batlevi, Philip C Caron, Pamela Drullinsky, Audrey Hamilton, Paul A Hamlin, Steven M Horwitz, Anita Kumar, Matthew J Matasar, Alison J Moskowitz, Colette N Owens, Maria Lia Palomba, Anas Younes, David J Straus
Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma. Blood 133 (20) (2019)